Cambridge Cognition partners with The Cure Parkinson's Trust We are delighted to announce that the neuroscience technology company Cambridge Cognition has selected The Cure Parkinson's Trust (CPT) to be their 2017 Charity of the Year. The team at Cambridge Cognition will organise a series of fundraising activities and all money raised in 2017 will support the research of The Cure Parkinson's Trust - including our treatment development programme testing repurposed drugs (Linked Clinical Trials). Dr Jenny Barnett, Director of Science at Cambridge Cognition, said: After a very successful year of fundraising in 2016 we have decided to raise money in support of The Cure Parkinson’s Trust for 2017. The Cure Parkinson’s Trust funds research with the aim to cure Parkinson’s – funding for research is vital to finding a cure, which is why we want to help. We hope our fundraising efforts will help towards finding that cure and we look forward to working with CPT throughout the year and beyond. ‘We are delighted to have been chosen to be the beneficiary charity for Cambridge Cognition in 2017.’ said Helen Matthews, Chief Operating Officer at The Cure Parkinson’s Trust. ‘We are also looking forward to finding out more about the important research work Cambridge Cognition are undertaking in Parkinson’s and how we can integrate their developments into our work .’ Cambridge Cognition is a science and technology company which develops cognitive software (CANTAB) for use in clinical trials and academic research, to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. Parkinson’s disease has been a primary focus for the company and their work includes neuropsychological tests for detecting the cognitive changes in Parkinson’s disease. To follow Cambridge Cognition's fundraising efforts in 2017, visit their JustGiving page here. If you are interested in becoming a Corporate Partner of The Cure Parkinson's Trust or would like to find out more about corporate fundraising, please email Maisie or call 020 7487 3892, or click here.